These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15254739)

  • 1. The subunits of glutamate cysteine ligase enhance cisplatin resistance in human non-small cell lung cancer xenografts in vivo.
    Fujimori S; Abe Y; Nishi M; Hamamoto A; Inoue Y; Ohnishi Y; Nishime C; Matsumoto H; Yamazaki H; Kijima H; Ueyama Y; Inoue H; Nakamura M
    Int J Oncol; 2004 Aug; 25(2):413-8. PubMed ID: 15254739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
    Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
    Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer.
    Inoue Y; Tomisawa M; Yamazaki H; Abe Y; Suemizu H; Tsukamoto H; Tomii Y; Kawamura M; Kijima H; Hatanaka H; Ueyama Y; Nakamura M; Kobayashi K
    Int J Oncol; 2003 Nov; 23(5):1333-9. PubMed ID: 14532974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts.
    Némati F; Daniel C; Arvelo F; Legrier ME; Froget B; Livartowski A; Assayag F; Bourgeois Y; Poupon MF; Decaudin D
    Anticancer Drugs; 2010 Jan; 21(1):25-32. PubMed ID: 19823076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin regulation of glutamate cysteine ligase catalytic and modifier subunit expression in rat ovary is subunit and follicle stage specific.
    Tsai-Turton M; Luderer U
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E391-402. PubMed ID: 15811874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
    Merk J; Rolff J; Dorn C; Leschber G; Fichtner I
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):e29-33. PubMed ID: 21420313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous.
    Dalton TP; Dieter MZ; Yang Y; Shertzer HG; Nebert DW
    Biochem Biophys Res Commun; 2000 Dec; 279(2):324-9. PubMed ID: 11118286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit.
    Lavoie S; Chen Y; Dalton TP; Gysin R; Cuénod M; Steullet P; Do KQ
    J Neurochem; 2009 Mar; 108(6):1410-22. PubMed ID: 19183254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Nishimura M; Ueda N; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Feb; 13(2):217-22. PubMed ID: 15643501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and analysis of Ancylostoma ceylanicum glutamate-cysteine ligase.
    Wiśniewski M; Lapiński M; Zdziarska A; Długosz E; Bąska P
    Mol Biochem Parasitol; 2014 Aug; 196(1):12-20. PubMed ID: 25092620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an E-box motif as a transcriptional repressor element in the proximal promoter region of the GCLC gene in rat lung epithelial L2 cells.
    Cheng LL; Li B; Luo JD; Tu HB; Liu QC; Ran P
    Free Radic Biol Med; 2005 Oct; 39(8):1030-40. PubMed ID: 16198230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of glutamate-cysteine ligase during mouse development.
    Díaz D; Krejsa CM; Kavanagh TJ
    Mol Reprod Dev; 2002 May; 62(1):83-91. PubMed ID: 11933164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway.
    Liu LZ; Zhou XD; Qian G; Shi X; Fang J; Jiang BH
    Cancer Res; 2007 Jul; 67(13):6325-32. PubMed ID: 17616691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between the catalytic and modifier subunits of glutamate-cysteine ligase.
    Yang Y; Chen Y; Johansson E; Schneider SN; Shertzer HG; Nebert DW; Dalton TP
    Biochem Pharmacol; 2007 Jul; 74(2):372-81. PubMed ID: 17517378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) correlates with cisplatin resistance in human non-small cell lung cancer xenografts.
    Nakagawa T; Inoue Y; Kodama H; Yamazaki H; Kawai K; Suemizu H; Masuda R; Iwazaki M; Yamada S; Ueyama Y; Inoue H; Nakamura M
    Oncol Rep; 2008 Aug; 20(2):265-70. PubMed ID: 18636185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of glutathione synthesis in macrophages by oxidized low-density lipoproteins is mediated by consensus antioxidant response elements.
    Bea F; Hudson FN; Chait A; Kavanagh TJ; Rosenfeld ME
    Circ Res; 2003 Mar; 92(4):386-93. PubMed ID: 12600891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
    Yamaguchi H; Kidachi Y; Kamiie K; Noshita T; Umetsu H; Fuke Y; Ryoyama K
    Biochem Pharmacol; 2013 Aug; 86(4):458-68. PubMed ID: 23791871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate-cysteine ligase attenuates TNF-induced mitochondrial injury and apoptosis.
    Botta D; Franklin CC; White CC; Krejsa CM; Dabrowski MJ; Pierce RH; Fausto N; Kavanagh TJ
    Free Radic Biol Med; 2004 Sep; 37(5):632-42. PubMed ID: 15288121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.